Suchergebnisse - "Yilmaz, Sarper"

PubPharm (87)

21

Emergency Medicine Association of Turkey Disaster Committee Summary of Field Observations of February 6th Kahramanmaraş Earthquakes

enthalten in: Prehospital and disaster medicine | 2023

von Yılmaz, S. | Karakayali, O. | Yilmaz, S. | +10

22

Agreement of Oscillometric and Auscultatory blood pressure measurement methods : An ambulance noise simulation study

enthalten in: The American journal of emergency medicine | 2023

von Tatliparmak, A. | Yilmaz, S.

23

Impact of rigid cervical collars on the vital signs and cervical vasculature : Should we be on the alert for anything?

enthalten in: The American journal of emergency medicine | 2023

von Tatliparmak, A. | Yilmaz, S.

24

Factors influencing recurrent emergency department visits for mild acute respiratory tract infections caused by the influenza virus

enthalten in: PeerJ | 2023

von Tatlıparmak, A. | Alpar, S. | Yilmaz, S.

25

Hesitancy Regarding Medical Advice on COVID-19 : An Emergency Department Perspective

enthalten in: Disaster medicine and public health preparedness | 2022

von Yilmaz, S. | Çolak, F. | Hökenek, N. | +1

26

Vaccine Hesitancy of Health-Care Workers : Another Challenge in the Fight Against COVID-19 in Istanbul

enthalten in: Disaster medicine and public health preparedness | 2022

von Yilmaz, S. | Çolak, F. | Yilmaz, E. | +3

27

Problems and Overcoming Methods of Emergency Medicine Specialists Working at Border Points

enthalten in: Disaster medicine and public health preparedness | 2022

von Yılmaz, S.

28

Direct (New) Oral Anticoagulants (DOACs) : Drawbacks, Bleeding and Reversal

enthalten in: Cardiovascular & hematological agents in medicinal chemistry | 2022

von Karcioglu, O. | Zengin, S. | Ozkaya, B. | +6

29

An Update of the Efficacy and Comparative Characteristics of Direct (New) Oral Anticoagulants (DOACs)

enthalten in: Cardiovascular & hematological agents in medicinal chemistry | 2022

von Karcioglu, O. | Yilmaz, S. | Afacan, G. | +6

30

Direct (New) Oral Anticoagulants (DOACs): Drawbacks, Bleeding and Reversal

enthalten in: Cardiovascular & hematological agents in medicinal chemistry | 2022

von Karcioglu, O. | Zengin, S. | Ozkaya, B. | +6